Off-The-Shelf Third-Party HSC-Engineered iNKT Cells for Ameliorating GvHD While Preserving GvL Effect in the Treatment of Blood Cancers

Scientists reported the successful generation of third-party hematopoietic stem cell (HSC)-engineered human invariant natural killer T (iNKT) cells, using a method combining HSC gene engineering and in vitro HSC differentiation.
AbstractFull ArticleGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News